While progress has been made, women continue to be underrepresented in clinical trials — affecting treatment protocols and delaying access to lifesaving therapies. This guide examines the historical context, ongoing challenges, and the urgent need for equitable inclusion in oncology studies.
Download this guide to learn more about:
- The pivotal role of the NIH and the Office of Research on Women’s Health in shaping more inclusive research practices
- The impact of delayed inclusion in oncology trials on gender-specific outcomes
- Strategies to improve patient education and engagement
- Proven approaches to trial accessibility and retention
Download the Guide
By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Premier Research that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.